Low-income patients skip rheumatoid arthritis meds

Low-income patients skip rheumatoid arthritis meds
Electronic monitoring shows that ethnically diverse and economically disadvantaged patients with rheumatoid arthritis have low adherence to oral disease-modifying antirheumatic drugs and poorer outcomes, according to a study published in the June issue of Arthritis & Rheumatism.

(HealthDay)—Electronic monitoring shows that ethnically diverse and economically disadvantaged patients with rheumatoid arthritis (RA) have low adherence to oral disease-modifying antirheumatic drugs (DMARDs) and poorer outcomes, according to a study published in the June issue of Arthritis & Rheumatism.

Christian A. Waimann, M.D., of the University of Texas MD Anderson Cancer Center in Houston, and colleagues conducted a two-year prospective cohort study to examine adherence to oral drug therapies and outcomes in patients with RA who received care at publicly funded clinics. Intake of oral RA medications was monitored in 107 patients using the Medication Event Monitoring System, an electronic medication monitoring system. The Disease Activity Score in 28 joints (DAS28) and radiographic scores of joint damage were used to assess outcomes.

The researchers found that patients received 64 percent of correct doses for DMARDs and 70 percent of correct doses for prednisone. Twenty-three patients (21 percent) had adherence to oral medications averaging 80 percent or greater. Across two years of follow-up, patients with at least 80 percent adherence to oral drug therapy had significantly better mean DAS28 values (3.28 versus 4.09) and less radiographic evidence of joint damage at 12 months compared with baseline.

"Our findings should alert physicians about the need to integrate adherence assessments into daily practice, to explore potential barriers to non-adherence, and to engage in discussions with patients to highlight the importance of taking medications as prescribed to reach therapeutic target goals," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Fracture risk down with adherence to bisphosphonates

Jan 03, 2013

(HealthDay)—For patients with an osteoporotic fracture, adherence to bisphosphonate treatment is associated with reduced fracture risk; and for veterans with rheumatoid arthritis, non-adherence to bisphosphonate ...

Systematic screening of med adherence will ID barriers

May 22, 2013

(HealthDay)—Implementation of systematic monitoring for medication adherence will allow for identification of barriers to adherence and tailoring of interventions, according to a viewpoint piece published ...

Meds adherence self-report valid in type 2 diabetes

Dec 20, 2012

(HealthDay)—Self-reported measures of medication adherence in adults with type 2 diabetes are valid, although some self-reports are moderated by depression, according to a study published online Nov. 30 ...

Recommended for you

Increased insulin resistance in rheumatoid arthritis

Dec 11, 2014

(HealthDay)—Patients with rheumatoid arthritis (RA) have elevated insulin resistance (IR), but this is not associated with increased atherosclerosis risk, according to a study published online Dec. 10 in ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.